Focus on enzyme replacement therapy in PKU patients


Guest Editor: Alberto Burlina, MD Ph.D

Professor of Pediatrics, Director of Division of Inherited Metabolic Diseases, Reference Centre Expanded Newborn Screening, University Hospital Padova, Padova, Italy


JIM 2025; 2 (Suppl 1): e951
DOI: 10.61012_20257_951

Why re-think dietary treatment in PKU?

JIM 2025; 2 (Suppl 1): e954
DOI: 10.61012_20257_954

Assessment of executive functions, adaptive skills, emotional and behavioral outcomes from pediatric age to adulthood in patients with PKU: a systematic review

JIM 2025; 2 (Suppl 1): e956
DOI: 10.61012_20257_956

Diet in patients with phenylketonuria treated with pegvaliase: a narrative review on the state-of-the-art and challenges

JIM 2025; 2 (Suppl 1): e958
DOI: 10.61012_20256_958

Adult phenylketonuria: transition management and follow-up